← Back to work
Works cited by this work
23 works
Work: Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan
Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis
Mayara Lisboa Bastos, Hamidah Hussain, Karin Weyer +82
Review article20144 citationsABICounting Pyrazinamide in Regimens for Multidrug-Resistant Tuberculosis
Molly F. Franke, Mercedes C. Becerra, Dylan B. Tierney +5
Article20153 citationsABIEfficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
Rodney Dawson, Andreas H. Diacon, Daniel E. Everitt +16
Article20152 citationsABIA Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis
Michael G. Whitfield, Heidi M. Soeters, Robin M. Warren +5
Review article20152 citationsABI